Not available
Quote | Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
Last: | $1.30 |
---|---|
Change Percent: | 3.08% |
Open: | $1.26 |
Close: | $1.30 |
High: | $1.34 |
Low: | $1.26 |
Volume: | 862,786 |
Last Trade Date Time: | 10/10/2023 03:00:00 am |
News | Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINE PR Newswire New product in development diversifies portfolio to drive long-term growth Innovative potential new therapeutic option for rare/orphan neuropsychiatric disorders w...
DEVON, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today reminds all stockholders, including individual stockholders, to prompt...
Message Board Posts | Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ZYNE News Article - Zynerba Pharmaceuticals Presents Data on Zygel(TM) at the 55th Gat | whytestocks | investorshangout | 04/12/2023 12:00:45 PM |
whytestocks: $ZYNE News Article - Zynerba Pharmaceuticals Announces Poster Presentations at the 55th | whytestocks | investorshangout | 04/05/2023 12:30:46 PM |
whytestocks: $ZYNE News Article - Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 | whytestocks | investorshangout | 03/28/2023 2:30:46 PM |
whytestocks: $ZYNE News Article - Zynerba Pharmaceuticals Announces Publication in the Journal of Ne | whytestocks | investorshangout | 01/11/2023 5:30:54 PM |
whytestocks: $ZYNE News Article - Zynerba Pharmaceuticals Announces Positive Long-Term Data from Pha | whytestocks | investorshangout | 12/05/2022 1:55:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Zynerba Pharmaceuticals Inc. Company Name:
ZYNE Stock Symbol:
NASDAQ Market:
Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba Pharmaceuticals, Inc...
HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINE PR Newswire New product in development diversifies portfolio to drive long-term growth Innovative potential new therapeutic option for rare/orphan neuropsychiatric disorders w...
DEVON, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced tr...